Dr Philippe Seiler > Bär & Karrer Ltd. > Zurich, Switzerland > Lawyer Profile
Bär & Karrer Ltd. Offices
- Go to...
Dr Philippe Seiler
Philippe Seiler has broad experience in international and domestic private M&A transactions in various industries with a special focus on life science and health care transactions (incl. medtech, pharma, healthcare providers in various industries, suppliers to healthcare providers etc.). Philippe Seiler does not only cover big size transactions and takeovers but also focuses on small- and mid-size M&A transactions, private equity transactions as well as venture capital and startup transactions. Furthermore, he advises clients on regulatory matters relating to life science and health care law outside of M&A transactions.
Philippe Seiler is praised for his pragmatic and solution-oriented advice while at the same time having an excellent technical knowledge. Due to his extensive transaction experience he has a fast and good understanding of the business and the process. Legal 500 ranks Philippe Seiler as a Key Contact for Healthcare and Life Sciences transactions and Who’s Who Legal lists him in M&A and Governance. In addition, Philippe Seiler was listed as a “Rising Star in Corporate/M&A/Private Equity” by Legal Media Group.
Philippe Seiler has frequent speaking engagements on M&A-related topics and teaches regularly at a number of private and public Universities (e.g. LL.M. of the University of Zurich, Switzerland; Executive MBA University of St. Gallen).
- Partner at Bär & Karrer (since 2019)
- Associate at Bär & Karrer (2012-2018)
- Trainee at Bär & Karrer (2010-2011)
- Research and Teaching Assistant to Prof. Dr. Alfred Koller (2007-2009)
- Swiss Bar Association (SAV/FSA)
- Zurich Bar Association (ZAV)
- AIJA (International Association of Young Lawyers)
- University of Chicago: LL.M. (2015)
- Zurich Bar Exam (2012)
- University of St.Gallen: Dr.iur. (2011)
- University of St.Gallen: lic.iur. (2008)
Bär & Karrer Ltd. is a go-to counsel for Swiss and foreign life sciences companies, public and private institutions and subsidiaries of international groups, including hospitals, care homes and clinics. The group covers private and public M&A and capital markets transactions, patent litigation and other disputes. Internal investigations in the pharmaceutical industry are also handled. Markus Schott is a specialist in regulatory questions, while Markus Wang covers IP-law, R&D and marketing/distribution. Philippe Seiler is a key contact for transactions.
Bär & Karrer Ltd. is appreciated for offering a ‘combination of legal skills with a business mindset.’ With Christoph Neeracher, Philippe Seiler and Raphael Annasohn, the firm can showcase a ‘powerhouse team‘ with strong experience in private M&A and private equity deals. Rolf Watter, Mariel Hoch and Dieter Dubs are specialists in public transactions. The practice is particularly well versed in the life sciences and pharmaceutical, real estate and financial services sectors. Luca Jagmetti is the key contact for transport and logistic clients. Thomas Rohde advises on restructurings. Martin Anderson is the name to note in Geneva.
|Switzerland: Private Equity||January 2022||This country-specific Q&A provides an overview to Private Equity laws and regulations that may occur in Switzerland.|
Top Tier Firm Rankings
- Banking and finance: Zurich
- Commercial, corporate and M&A
- Dispute resolution: arbitration
- Dispute resolution: litigation
- Healthcare and life sciences
- Leading firms: German-speaking Switzerland
- Leading firms: Italian-speaking Switzerland
- Private client
- Public law
- Real estate and construction
- Regulatory, compliance and investigations
- Sports law